HIGHLIGHTS   |  November 9, 2019   Genomic Testing Costs Not Always Addressed by Oncologists, Survey Says Conversations about the financial realities of genomic testing are not always taking place, according to a new study by the American Cancer Society. Read more     MD Anderson Partners with Takeda to Develop CAR Natural Killer-Cell Therapy The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered an exclusive license agreement and research agreement to develop and market chimeric antigen receptor-directed natural killer-cell therapies. Read more IN CASE YOU MISSED IT   Dr. William Wood on the Clinical Risk of Chemo in Early Breast Cancer CancerNetwork® spoke with Dr. William Wood, professor of medicine at Emory University in Atlanta, Georgia, about the clinical risk of chemotherapy in early breast cancer. Read more